Aishwarya Lifesciences retains India Juris

01 May 2014

Aishwarya Lifesciences is among TOP-5 companies in India, producing sterile solutions using FFS technology. It is an associate company of Alkem Laboratories, one of the leaders in Indian Pharmaceutical industry.

Aishwarya Lifesciences has retained India Juris in a dispute resolution matter against a large corporation.

News & Deals

India Juris Advises on Hoopr’s Pre-Series A Funding Round

IJ acted as legal counsel to the investor on its Pre-Series A investment in Rotoris

In INR 32.5 Cr funding round of 1BUY.AI, IJ represents lead investor

Obtaining a Payment Services Provider (PSP) Licence in GIFT IFSC: Regulatory Framework under IFSCA

Bridging Jurisdictions: Cross-Border Insolvency in The Gift City Paradigm

Reframing Liquidation Under IBC: Transitioning From Sale as a Going Concern to Asset-Based Realisation

The New 2026 IFSCA FinTech Sandbox Framework

The GIFT City Payment Gateway: PSP License

Amendment to “Guidelines on Cyber Security and Cyber Resilience for Regulated Entities in IFSCs”

Aishwarya Lifesciences retains India Juris

Aishwarya Lifesciences retains India Juris

News & Deals

India Juris Advises on Hoopr’s Pre-Series A Funding Round

IJ acted as legal counsel to the investor on its Pre-Series A investment in Rotoris

In INR 32.5 Cr funding round of 1BUY.AI, IJ represents lead investor

Publications

Obtaining a Payment Services Provider (PSP) Licence in GIFT IFSC: Regulatory Framework under IFSCA

Bridging Jurisdictions: Cross-Border Insolvency in The Gift City Paradigm

Reframing Liquidation Under IBC: Transitioning From Sale as a Going Concern to Asset-Based Realisation

Newsletters

The New 2026 IFSCA FinTech Sandbox Framework

The GIFT City Payment Gateway: PSP License

Amendment to “Guidelines on Cyber Security and Cyber Resilience for Regulated Entities in IFSCs”